Abstract
This perspective is a paper discussing drugs dropped from clinical development in the previous years. Specifically, this paper focuses on 16 cardiovascular drugs discontinued in 2010 after reaching Phase I - III clinical trials. Information for this perspective is mainly derived from a search of Pharmaprojects.
MeSH terms
-
Cardiovascular Agents / adverse effects
-
Cardiovascular Agents / pharmacology*
-
Clinical Trials as Topic
-
Drug Discovery*
-
Drugs, Investigational / adverse effects
-
Drugs, Investigational / pharmacology*
-
Humans
-
Product Recalls and Withdrawals*
-
United States
-
United States Food and Drug Administration
Substances
-
Cardiovascular Agents
-
Drugs, Investigational